Association between serum apolipoprotein CII concentration and coronary heart disease

Preventive Medicine

Volumn 35, Issue 1, 2002, Pages 42-47

  Gerber, Yariv ^a,b   Goldbourt, Uri ^b   Cohen, Hofit ^b   Harats, Dror ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Apolipoprotein CII; Case control studies; Coronary heart disease; Risk factors; Triglycerides

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; STATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SAMPLE SIZE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036315216     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.2002.1045     Document Type: Article

References (36)

1. Serum cholesterol, lipoproteins, and the risk of coronary heart disease
2. Hyperlipidemia and atherosclerosis
3. The Lipid Research Clinics Coronary Primary Trial results. I Reduction in incidence of coronary heart disease
4. Lowering blood cholesterol to prevent heart disease
5. HDL cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phenotyping study
6. Plasma high density lipoprotein concentration and development of ischemic heart disease
7. High density lipoprotein cholesterol and incidence of coronary heart disease: The Israeli Ischemic Heart Disease study
8. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham study
9. Atherogenicity of triglyceride-rich lipoproteins
10. Triglyceride lipases and atherosclerosis
11. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins
12. Plasma triglyceride as a risk factor for coronary heart disease
13. Triglyceride concentration and coronary heart disease
14. Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: The Bezafibrate Infarction Prevention (BIP) registry
15. Does measurement of apolipoproteins add to the clinical diagnosis and management of dyslipidaemias?
16. II: A study in normal and hypertriglyceridemic subjects
17. Quantitative determination of apolipoproteins CI and CII in human plasma by separate electroimmunoassays
18. III
19. Cofactor activity of protein components of human very low density lipoprotein in the hydrolysis of triglycerides by lipoprotein lipase from different sources
20. Role of apoCs in lipoprotein metabolism: Functional differences between apoC1, apoC2, and apoC3
21. Apolipoprotein CII and CIII levels in hyperlipoproteinemia
22. Distribution of CII and CIII peptides in lipoprotein classes: Methods and clinical significance
23. III in peripheral arterial disease
24. Quantitation of serum apolipoprotein A-I, A-II, B, CII, CIII and E in healthy Japanese
25. Lipoproteins and apolipoproteins
26. Inheritance of apolipoprotein CII deficiency with hypertriglyceridemia and pancreatitis
27. Structure and functional properties of apolipoprotein CII
28. Genetic dyslipoproteinemias: Role of lipoprotein lipase and apolipoprotein CII
29. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice
30. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoprotein A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) study
31. Hypertriglyceridemia as a cardiovascular risk factor
32. Risk factors for coronary heart disease in the prospective Dubbo Study of Australian elderly
33. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years
34. Mechanisms of inhibition by apolipoprotein C or apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway
35. Serum lipids four weeks after acute myocardial infarction are a valid basis for lipid lowering intervention in patients receiving thrombolysis
36. Myocardial injury: The acute phase response and lipoprotein metabolism